IS 11C-CHOLINE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY ACCURATE TO DETECT NODAL RELAPSES OF PROSTATE CANCER AFTER BIOCHEMICAL RECURRENCE? A MULTICENTRIC STUDY BASED ON PATHOLOGIC CONFIRMATION FROM SALVAGE LYMPHADENECTOMY ArticleOderda M., Palazzetti A., Falcone M., Melloni G., Gontero P., Joniau S., Van Den Bossche H., Deconinck S., Zattoni F., Karnes R.J.European Urology Focus. Vol. 4. 2018. P.. 288-293
TARGETING CD46 FOR BOTH ADENOCARCINOMA AND NEUROENDOCRINE PROSTATE CANCER ArticleSu Y., Liu Y., Behrens C.R., Bidlingmaier S., Lee N.K., Liu B., Aggarwal R., Sherbenou D.W., Shuman M.A., Small E.J., Hann B.C., Simko J.P., Premasekharan G., Paris P.L., Burlingame A.L., Seo Y.JCI Insight. Vol. 3. 2018.